Key statistics dashboard for Creative Medical Technology Holdings, Inc. (CELZ). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology.
Stock Data
| Price | $0.82 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.44 |
| Price / Book | 0.38 |
| P/S | 761.29 |
| P/FCF | -0.39 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -1732.37% |
| EBIT Margin | -206767.73% |
| EBITDA Margin | -202975.03% |
| Operating Margin | -208004.40% |
| Net Margin | -201355.37% |
Financial Health
| Current Ratio | 12.91 |
| Quick Ratio | 12.73 |
| Cash Ratio | 12.47 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -4.32 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 2.34 |
| Cash per share | 2.35 |
| FCF per share | -1.59 |
| Tangible Book Value per share | 2.25 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Related companies: ACXP · ADIL · ADXN · ALZN · APRE · BCDA · CDIO
Explore sector: Healthcare · Biotechnology
More sections of CELZ: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks